Sofinnova Partners

Paris, France

Quick Facts

AUM
$1B-$5B
AUM Category
$1B-$5B
Headquarters
Paris, France
Founded
1972
Team Size
50-100

About Sofinnova Partners

Sofinnova Partners is a prominent European venture capital and private equity firm, primarily focusing on the life sciences sector. Founded in 1972 and headquartered in Paris, the firm operates with a distinct investment philosophy centered on identifying and nurturing innovative companies that address unmet medical needs. Sofinnova Partners typically engages in early to growth-stage investments, aiming to leverage its deep sector expertise to catalyze company development and deliver value over the long term. Their deal thesis often involves partnering with visionary entrepreneurs and management teams to drive operational improvements and strategic growth initiatives that enhance the overall value proposition of their portfolio companies. The firm has a robust focus on the life sciences, particularly in biotechnology, pharmaceuticals, and medical devices. Sofinnova Partners seeks to invest in companies that are at the forefront of scientific advancement and innovation, often targeting businesses that demonstrate the potential to disrupt existing markets or create entirely new ones. Their portfolio encompasses a range of companies, from emerging biotech firms developing novel therapeutics to established medical device manufacturers. This sector specialization not only underscores the firm’s commitment to the life sciences but also provides a strategic advantage through its extensive network and industry knowledge. What distinguishes Sofinnova Partners in the private equity landscape is their long-standing commitment to the life sciences sector, combined with a collaborative approach to investment. The firm’s team is composed of experienced professionals with diverse backgrounds in science, medicine, and business, which enables them to provide valuable insights and guidance to their portfolio companies. This collaborative ethos fosters a partnership dynamic that is often appealing to interim executives and operating partners, as it emphasizes shared goals and mutual success. For interim executives considering a partnership with Sofinnova Partners, it is crucial to recognize the firm’s deep focus on innovation and operational excellence within the life sciences sector. Executives should be prepared to engage in a fast-paced environment that prioritizes scientific rigor and strategic execution. Understanding the firm’s investment criteria and operational expectations will be vital for aligning with their objectives and effectively contributing to the growth and development of portfolio companies. Additionally, leveraging the firm’s extensive industry network can provide valuable resources and connections that may enhance operational strategies and facilitate successful outcomes.

Investment Focus

Sectors: Healthcare, Technology

Investment Stages: Venture, Growth

Portfolio Focus: HealthTech, DeepTech

Regional Offices

  • San Francisco
  • London

Connect with Sofinnova Partners

Frequently Asked Questions

Is Sofinnova Partners a private equity firm?
Yes, Sofinnova Partners is a private equity firm headquartered in Paris, France, founded in 1972.
What is Sofinnova Partners's AUM (assets under management)?
Sofinnova Partners manages approximately $1B-$5B in assets under management.
Where is Sofinnova Partners headquartered?
Sofinnova Partners is headquartered in Paris, France. Regional offices include San Francisco, London.
What sectors does Sofinnova Partners invest in?
Sofinnova Partners invests across Healthcare, Technology.
What investment stages does Sofinnova Partners focus on?
Sofinnova Partners focuses on Venture, Growth investments.
When was Sofinnova Partners founded?
Sofinnova Partners was founded in 1972.

Profile data is compiled from publicly available sources and AI analysis for the Interim community. Information is not endorsed by Sofinnova Partners; verify critical details directly with the firm.